Clinical Trial Update: Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and antiviral activity of tipranavir (TPV) in HIV-infected patients coinfected with hepatitis C and/or hepatitis B; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B
• Hepatitis C

Drugs mentioned

• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: TERMINATED | Results posted: 2009-12-23